IL-17 contributes to autoimmune hepatitis - PubMed (original) (raw)

IL-17 contributes to autoimmune hepatitis

Haijing Yu et al. J Huazhong Univ Sci Technolog Med Sci. 2010 Aug.

Abstract

The role of interleukin-17 (IL-17) in autoimmune hepatitis (AIH) was investigated. A mouse model of experimental autoimmune hepatitis was established, and the syngeneic S-100 antigen emulsified in complete Freud's adjuvant was injected intraperitoneally into adult male C57BL/6 mice. The IL-17 expression in serum and the livers of the mice models was detected by using ELISA and immunohistochemistry, respectively. IL-17 neutralizing antibody was used to study the biological effect of IL-17 in the experimental AIH. IL-17 neutralizing antibody in vivo administration alleviated the hepatic inflammation and ALT level in the AIH model. IL-17 in the peripheral blood mononuclear cells (PBMC) of AIH patients was measured by using real-time PCR method. The results showed that IL-17 level was significantly up-regulated in AIH patients and mice models. It was concluded that IL-17 contributed to the development of AIH and might be a potential therapeutic target of AIH.

PubMed Disclaimer

References

    1. Nat Med. 2007 Jun;13(6):711-8 - PubMed
    1. Scand J Rheumatol. 2002;31(4):205-10 - PubMed
    1. Nat Med. 2002 May;8(5):500-8 - PubMed
    1. World J Gastroenterol. 2007 Aug 21;13(31):4249-54 - PubMed
    1. J Immunol. 1999 Jan 1;162(1):577-84 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources